Bactolac Pharmaceutical, Inc.

Founded in 1999, Empack Spraytech Inc. is a leading innovative and highly diversified aerosol manufacturer, liquid filler and custom contract packaging company located in Brampton, ON. We are ISO 9001:2008 and GMP Certified. Empack has a full Drug Establishment License (DEL) from Health Canada to manufacture drug products (DIN) such as sunscreens and is Site Licensed to manufacture Natural Health Products (NPN). We also offer product development and production for products requiring an NDC number from the FDA for the United States.

As a fully integrated, state-of-the-art manufacturing and marketing business, we offer on-site research & development, customized formulations, innovative product solutions, and supply chain reliability to companies across North America and Internationally. We focus on environmentally friendly solutions for the industries we serve.

Empack manufactures for a range of markets including:

• Personal Care
• Sun Care
• Household Products
• Automotive & Industrial
• Insecticides
• Computer & Electronics
• Shoe & Leather Care
• Outdoor
• Specialty Products

Dow combines global breadth, asset integration and scale, focused innovation, and leading business positions to achieve profitable growth. Our ambition is to become the most innovative, customer-centric, inclusive, and sustainable materials science company, with a purpose to deliver a sustainable future for the world through our materials science expertise and collaboration with our partners. Our portfolio of plastics, industrial intermediates, coatings and silicones businesses delivers a broad range of differentiated science-based products and solutions for its customers in high-growth market segments, such as packaging, infrastructure, mobility, and consumer care. We operate 106 manufacturing sites in 31 countries and employ approximately 35,700 people.

Clara Diagnostics is developing the Exosome Sorting System (ExoSS), a high-throughput microfluidic system for the isolation and purification of exosomes. The company aims to launch the first microfluidic exosome sorting device (ExoSS) into the marketplace for automated, high-specificity, and high throughput preparation of exact exosome subtypes from a variety of biofluids.
The ExoSS system performs isolation 100x faster than ultracentrifugation and able to extract greater than 90% of exosomes with an isolation purity greater than 90%. ExoSS rapidly runs parallel samples continuously, resulting in a platform ideal for large volume processing. Designed for low skill automation, ExoSS has the advantage of extracting all or only specific
types of exosomes from the biological source.
An On Site Non-Clinical Isolation Service (ExoSS OnSite) was launched in November 2018 by the company utilizing the existing ExoSS system.
Clara Diagnostics is focused on establishing strategic partnerships for development in diagnostic and therapeutic applications, equipment manufacturing, antibody sourcing, distribution, sales and marketing.

Established in 1952, Doran and Ward Packaging has developed a reputation as a printer that delivers value. Our diverse converting processes allow us to produce a variety of high end finished products on paper, film and board.

Doran and Ward has developed a niche printing high end flexographic and offset litho packaging for the health and beauty, cosmetics and pharmaceutical markets. Our proprietary innovations have developed longer and safer shelf lives of product at a lower cost- with better quality- than our competition.

Under current ownership for more than 25 years, our management team expect to deliver real, bottom line value to all our customers. We continue to innovate and diversify to exceed the expectations of our customers. Our customers are located around the world, but predominantly in North America and the Caribbean.

The core guiding principle of the Doran and Ward team is culture. It’s our unique culture that allows us to excel at handling complex and demanding order flow. Multiple SKU’s, short lead times, fast market introductions of new products, and repeated graphics changes are commonplace for Doran and Ward and our customer base. Many printers struggle with this type of customer, yet it’s our experience within this complicated market that places Doran and Ward in a class all its own.

Our end product offerings are limited only by imagination; including but not limited to:

• Paper cut and stack or wrap-around printed die-cut labels.
• Film roll applied labels and wraps, including laminated or mono web structures.
• Printed and die-cut folding cartons and related board products.
• Specialized marketing materials.

Industries currently served, in no particular order or priority:
• Health and beauty.
• Confections.
• Cosmetics.
• Consumer products.
• Beverage.
• Pet food.
• Automotive.

Visit our web site at www.doranandward.com

Specializing in the development and manufacture of innovative prescription and over-the-counter (OTC) therapies, privately held Fleming Pharmaceuticals is the proud maker of MAGONATE®, NEPHROCAPS®, NEPHROCAPS® QT, ThyroShield®, ProBarimin QT® and the OCEAN® Nasal Care line of products.

Established in 1960, the company has developed products for a variety of clinical conditions in allergy, pediatrics, nephrology, nutrition, and obstetrics/gynecology.

Based in the greater St. Louis area, our fully integrated headquarter facility houses state-of-the-art liquid and solid pharmaceutical manufacturing and packaging, analytical microbiological laboratories, research and development, distribution, marketing, and business administration functions.